Cover
Cover | Jan. 10, 2022 |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | This Amendment No. 1 to the Form 8-K (the “Form 8-K”) originally filed by Revelation Biosciences, Inc. (the “Company”) on January 14, 2022 is being filed solely for the purpose of amending the historical financial statements provided under Item 9.01(a) in the Form 8-K to include the audited financial statements of Revelation Biosciences Sub, Inc. (“Former Revelation”) as of December 31, 2021 and 2020 and for the period from May 4, 2020 (inception) to December 31, 2020 and the year ended December 31, 2021 and the related Management’s Discussion and Analysis of Financial Condition and Results of Operations of Former Revelation. This Amendment No. 1 does not amend any other item of the Form 8-K or purport to provide an update or a discussion of any developments at the Company subsequent to the filing date of the Form 8-K. |
Document Period End Date | Jan. 10, 2022 |
Entity File Number | 001-39603 |
Entity Registrant Name | REVELATION BIOSCIENCES, INC. |
Entity Central Index Key | 0001810560 |
Entity Tax Identification Number | 84-3898466 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 4660 La Jolla Village Drive |
Entity Address, Address Line Two | Suite 100 |
Entity Address, City or Town | San Diego |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92122 |
City Area Code | 650 |
Local Phone Number | 800-3717 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |
Units, each consisting of one share of common stock and one-half of one redeemable warrant | |
Title of 12(b) Security | Units, each consisting of one share of common stock and one-half of one redeemable warrant |
Trading Symbol | REVBU |
Security Exchange Name | NASDAQ |
Common stock, par value $0.001 per share | |
Title of 12(b) Security | Common stock, par value $0.001 per share |
Trading Symbol | REVB |
Security Exchange Name | NASDAQ |
Redeemable warrants, each exercisable for a share of common stock at an exercise price of $11.50 per share | |
Title of 12(b) Security | Redeemable warrants, each exercisable for a share of common stock at an exercise price of $11.50 per share |
Trading Symbol | REVBW |
Security Exchange Name | NASDAQ |